CLOV vs KNSA · rev $1.37B vs P/E 53, rev $423.2M
Clover Health Investments Corp (CLOV) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported KNSA revenue for 2024-12-31 was $423.2M. Net income was -$43.2M. Revenue was up 56.6% from 2023-12-31 to 2024-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
CLOV currently screens at market cap $1.55B. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the CLOV and KNSA stock pages for the full models.
Not investment advice.